Alnylam Pharmaceuticals | 税前利润

股票价格

328.16

每天变化

-3.08 -0.93%

每月一次

-22.33%

每年

18.82%

Q1 预测

318.09

金融业

USD

USD 4.85B

现金及等价物

USD 1.49B

USD 200.15M

USD 3.95B

USD 1.56B

USD 1.3B

USD -29.96M

USD 381.79M

2.23K

EPS每股收益

USD 2.9

股本和储备

USD 233.89M

USD 1.05B

债务利息支出

USD 44.4M

USD 27.49M

USD 1.04B

USD 43.23B

USD 251.08M

USD 881.04M

USD -29.96M

普通股股本

USD 131.79M

538.03

USD 238.97M

USD 1.25B

销售和管理费用

USD 262.59M

USD 75.38M

贸易债权人

USD 117.59M

应收帐款人

USD 964.77M

	税前利润	更改		日
Acadia Pharmaceuticals	USD 44.6M		4.38M	2025-09
Agios Pharmaceuticals	USD -103.43M		8.59M	2025-09
Alnylam Pharmaceuticals	USD 238.97M		274.33M	2025-09
Amgen	USD 3.92B		2.35B	2025-09
Arrowhead Research	USD 28.27M		7.85M	2025-12
BioMarin Pharmaceutical	USD -26.32M		324.19M	2025-09
Incyte	USD 482.31M		75.7M	2025-09
Ionis Pharmaceuticals	USD -129M		253M	2025-09
Moderna	USD -187M		631M	2025-09
Neurocrine Biosciences	USD 291.8M		132.3M	2025-09
Novartis	USD 5.17B		637M	2025-09
PTC Therapeutics	USD -23.07M		47.98M	2025-09
Regeneron Pharmaceuticals	USD 1.76B		244.6M	2025-09
Sanofi	EUR -1.16B		6.23B	2025-12
Sarepta Therapeutics	USD -194.05M		347.69M	2025-09
Takeda	JPY 133.86B		105.69B	2025-12
Tectonic Therapeutic	USD -19.04M		25K	2025-09
Ultragenyx Pharmaceutical	USD -179.54M		65.54M	2025-09
Vertex Pharmaceuticals	USD 1.3B		15.8M	2025-09
Xencor	USD -6.03M		25.05M	2025-09

Alnylam Pharmaceuticals 税前利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.